Histone H3 E50K mutation confers oncogenic activity and supports an EMT phenotype.
Sad K, Jones CY, Fawwal DV, Hill EJ, Skinner K, Lustenberger S, Lee RS, Elayavalli SR, Farhi J, Lemon LD, Fasken MB, Hong AL, Sloan SA, Corbett AH, Spangle JM.
Sad K, et al. Among authors: hill ej.
bioRxiv [Preprint]. 2024 Aug 1:2023.10.11.561775. doi: 10.1101/2023.10.11.561775.
bioRxiv. 2024.
PMID: 37873162
Free PMC article.
Preprint.